Liver alpha-amylase gene expression as an early obesity biomarker.
CONCLUSIONS: Elevated liver alpha-amylase levels may be indicative of initial stages of obesity and the use of acarbose could be considered as a treatment of obesity which could be potentially effective at multiple levels.
PMID: 28095353 [PubMed - indexed for MEDLINE]
Source: Pharmacological Reports - Category: Drugs & Pharmacology Authors: Mojbafan M, Afsartala Z, Amoli MM, Mahmoudi M, Yaghmaei P, Larijani B, Ebrahim-Habibi A Tags: Pharmacol Rep Source Type: research
More News: Acarbose | Cholesterol | Eating Disorders & Weight Management | Genetics | Liver | Men | Nutrition | Obesity | Pancreas | Statistics | Study | Urology & Nephrology